Editor's Note: Green and red arrows refer to intraday stock price movement.NEW YORK ( TheStreet) -- CHANGE IN RATINGS Baidu ( BIDU - Get Report) rated new Buy at Jefferies. $200 price target. Company is a market leader with limited competition. Comerica ( CMA - Get Report) rated new Market Perform at Morgan Keegan. $38 price target. Visibility remains low for potential loan growth. Fastenal ( FAST - Get Report) upgraded at UBS from Neutral to Buy. $72 price target. Estimates also boosted, as sales growth can drive margin expansion. Henry Schein ( HSIC) upgraded at Goldman to Buy, Goldman Sachs said. $80 price target. Industry should benefit from improving macro trends. Intermune ( ITMN) upgraded to Outperform at Wells Fargo. Expecting a more robust Esbriet launch. Perrigo ( PRGO) upgraded at from Sell to Neutral, Goldman Sachs said. $80 price target. Company can move past the FDA issue and should continue to realize synergies from recent deals. Riverbed Technology ( RVBD) upgraded at ThinkEquity from Hold to Buy. $48 price target. Guidance confirms recent checks that show demand can recover. Riverbed Technology ( RVBD) upgraded at Oppenheimer from Perform to Outperform, Oppenheimer said. $40 price target. Company pre-announced to the upside, easing some demand concerns. Sirona Dental ( SIRO) rated new Buy at Goldman. Company was also addded to the Conviction Buy list. Company is leverage to increased spending on high-tech equipment. $61 price target. Sunoco ( SUN - Get Report) downgraded at Benchmark from Hold to Sell, Benchmark Company said. $34 price target. Company is facing an unfavorable settlement for coke pricing. Dentsply ( XRAY - Get Report) rated new Neutral at Goldman Sachs. $39 price target. Stock is already pricing in improving industry growth. End of report.
More from Stocks
Microsoft Tops Estimates on Enterprise Strength: 10 Key Takeaways
The software giant reported double-digit growth for a slew of major businesses. And outside of some gaming headwinds, it expects the December quarter to be strong as well.
Tesla Changes Up Format of Shareholder Call, In Addition to Posting Profit
On its third-quarter call, Tesla management incorporated several questions from unidentified investors before turning to Wall Street analysts.
F5 Networks Shares Advance After Fourth-Quarter Results Beat Estimates
Revenue at the Seattle network-security and -optimization provider rose 4.9%.
Johnson & Johnson Confirms $4 billion 'Agreement in Principle' Opioid Settlement
Johnson & Johnson confirmed Wednesday that it will contribute $4 billion to a liability fund amid at redressing victims of the nation's opioid crisis, noting the payment will hive its previously-reported third quarter earnings.